Case Report: A Squamous Cell Lung Carcinoma Patient Who Responded to Neoadjuvant Immunochemotherapy but Died From Anastomosis Leakage or/and irAEs: Immune Microenvironment and Genomic Features Changes

Clinical trials indicated that PD-1/PD-L1 inhibitors significantly improve the survival rate of patients with advanced non-small cell lung cancer (NSCLC) and induce immune-related adverse events (irAEs). Thus, the molecular and immune characteristics during PD-1/PD-L1 inhibitor therapy are worth inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Liping, Hu, Ying, Hu, Jianjun, Liu, Yang, Mao, Beibei, Chen, Huan, Gong, Xiaoli, Wang, Di, Wang, Lin, Wang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339907/
https://www.ncbi.nlm.nih.gov/pubmed/34367960
http://dx.doi.org/10.3389/fonc.2021.674328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339907/
https://www.ncbi.nlm.nih.gov/pubmed/34367960
http://dx.doi.org/10.3389/fonc.2021.674328

Ejemplares similares